NewAmsterdam Pharma Company NV Warrant
Quarterly Financials
| Values in thousands | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 |
|---|---|---|---|---|
Revenue | $12,772 | $29,111 | $2,127 | $1,298 |
Gross Profit | 12,772 | 29,111 | 2,109 | 1,298 |
EBITDA | -111,693 | -23,840 | -49,061 | -54,574 |
EBIT | -111,744 | -23,868 | -49,078 | -54,587 |
Net Income | -92,177 | -16,647 | -36,413 | -86,893 |
Net Change In Cash | 12,772 | 29,111 | 2,127 | 1,298 |
Free Cash Flow | -37,484 | -12,577 | -50,492 | -51,165 |
Cash | 771,743 | 422,729 | 401,333 | 414,927 |
Basic Shares | 94,358 | 94,754 | 94,711 | 82,160 |
Annual Financials
| Values in thousands | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
Revenue | $45,563 | $12,762 | $95,905 | $0 |
Gross Profit | 45,563 | 12,762 | 95,905 | -14 |
EBITDA | -241,486 | -176,861 | -3,313 | -30,726 |
EBIT | -241,599 | -176,910 | -3,321 | -30,730 |
Net Income | -241,598 | -176,937 | -21,137 | -36,712 |
Net Change In Cash | 45,563 | 12,762 | 95,905 | 0 |
Free Cash Flow | -159,236 | -141,242 | 7,959 | -25,184 |
Cash | 771,743 | 340,450 | 438,522 | 53,092 |
Basic Shares | 94,358 | 82,161 | 18,966 | 17,751 |
